Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
The US Food and Drug Administration confirmed Thursday that EliLilly (LLY) has increased production of its blockbuster weight-lossdrug ... its drugs were nolongerin shortage, ...
Oct 7 (Reuters) - A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take EliLilly’s (LLY.N), opens new tab blockbuster weight ...
The Food and Drug Administration on Friday said it would reconsider its decision to remove EliLilly’s tirzepatide ... compounding pharmacies would nolonger be permitted to manufacture and ...